This study aimed to determine whether patients with PRES-SLE have a specific blood cytokine profile. They also assessed soluble CD40L and VEGF, two markers directly linked to systemic endothelial injury. The gene discussed is VEGFA; the disease is Posterior Leukoencephalopathy Syndrome.